Purchase Order 75N94024P00696
Award Date 9/16/24
Potential Completion Date 9/15/25
Potential Value $126K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $81,714.96 firm fixed-price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of intravenous stable isotope glucose (D5 glycerol) to support metabolic research. The contract has an ultimate completion date of April 30,...
- This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services. The $69,466.32 firm fixed-price delivery order was awarded to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is for the provision of intravenous stable isotope glucose (6,6 deuterated glucose) to support metabolic research. The contract has a...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $12,580.80 contract is for the acquisition of intravenous stable isotopes, which are specialized pharmaceutical compounds used in metabolic and clinical research studies. Pine Pharmaceuticals is an...
- This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC for the procurement of intravenous stable isotope (6,6 D2-Glucose) for metabolic research. The $138,712.14 contract has an ultimate completion date of November 2, 2024 and was awarded on a sole-source basis without a small business set-aside. Pine Pharmaceuticals is an...
- This is a federal delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company. The $158,877.60 firm fixed price contract is for the provision of metabolic isotopes, a non-severable service, with a performance period ending on April 13, 2026. Pine Pharmaceuticals is an FDA-registered 503B outsourcing...
- This is a firm-fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company. The contract is for the procurement of 6,6 D2-glucose 72.9 mg/ml (30 ml) vials, which are likely being used to support metabolic research studies conducted by NICHD. The contract has a ceiling value of $12,371.12 and a period of...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Department of Health and Human Services, awarded a $44,606.40 firm fixed-price purchase order to Pine Pharmaceuticals LLC, a small business contractor located in Tonawanda, New York. The contract is for the acquisition of intravenous stable isotopes, specifically D5 glycerol and 6,6 D2-glucose, to support metabolic research. This award is not associated with a larger contract vehicle. The contract has a...
- The National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $237,922.80 firm fixed price purchase order to Pine Pharmaceuticals LLC. The purpose of this acquisition is to procure an intravenous stable isotope to support metabolic research studies being conducted by the funding agency. The solicitation sought a stable isotope that meets NIH specifications for use in clinical human research, referencing a history of safe use in such studies. No...
- This $116,700.00 firm fixed price purchase order was awarded to Pine Pharmaceuticals LLC, a for-profit limited liability company, by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations. The contract has a completion date of August 17, 2023 and does not have a set-aside designation. Based on the information provided, Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that has previously provided pharmaceutical...
- This is a $121,989 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The contract is to provide specialized pharmaceutical products and services, including the manufacture of stable isotopes, placebo capsules, and other compounds used in medical...